Bio-Tech & Healthcare Industries

Market Overview

The biotechnology and healthcare sectors represent some of the most impactful investment opportunities available today. We focus on companies and projects at the intersection of scientific innovation and commercial viability, supporting ventures that can meaningfully improve patient outcomes.

Our healthcare investments span the full spectrum from medical device manufacturers and diagnostic companies to healthcare facility development and pharmaceutical distribution. We prioritise opportunities with clear regulatory pathways, strong intellectual property positions, and experienced clinical and commercial teams.

We recognise the unique timelines and risk profiles inherent in life sciences investing, and our flexible capital structures are designed to support the longer development cycles that characterise this sector.

Opportunity

Aging populations, chronic disease prevalence, and continuous medical innovation are driving durable demand for healthcare and life sciences solutions. The sector offers opportunities across medical devices, diagnostics, facility development, pharmaceutical services and digital health platforms.

Our Approach

We provide growth capital, project finance for healthcare facilities, equipment financing and selective venture positions. We prefer assets and companies with commercial traction, defendable intellectual property or contracted revenue streams.

Risk Management

Risk is managed through stage-gate capital release, milestone-based triggers, diversified sub-sector exposure, independent technical and regulatory review, and careful evaluation of reimbursement and commercial risk.

Investment Criteria

• Clear regulatory pathway and reimbursement visibility
• Strong intellectual property or proprietary technology
• Experienced clinical, technical and commercial leadership
• Demonstrated product-market fit or revenue generation
• Sustainable competitive advantage and margin profile